Global Immunodiagnostics Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	184 Pages	TechNavio	June, 2024	INF19006686

Best Price Guarantee
Price	from $2,500
Length	184 Pages
Publisher	TechNavio
Published Date	June, 2024
SKU	INF19006686

Global Immunodiagnostics Market 2024-2028

The immunodiagnostics market is forecasted to grow by USD 29545.4 mn during 2023-2028, accelerating at a CAGR of 13.64% during the forecast period. The report on the immunodiagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased demand for biomarker-based tests, advancements in technology in immunodiagnostics, and rising geriatric population.

Technavio's immunodiagnostics market is segmented as below:

By Product

Reagents and consumables
Immunodiagnostic systems

By Application

Oncology and endocrinology
Hepatitis and retrovirus
Infectious disease
GI stool
Other applications

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growth in demand for personalized medicine as one of the prime reasons driving the immunodiagnostics market growth during the next few years. Also, emergence of point-of-care testing (poct) and rising demand for automated systems will lead to sizable demand in the market.

The report on the immunodiagnostics market covers the following areas:

Immunodiagnostics market sizing
Immunodiagnostics market forecast
Immunodiagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunodiagnostics market vendors that include Abbott Laboratories, Adaptive Biotechnologies Corp., AESKU.GROUP GmbH and Co. KG, bioMerieux SA, Danaher Corp., DiaSorin SpA, Exagen Inc., F. Hoffmann La Roche Ltd., HUMAN Gesellschaft fur Biochemica und Diagnostica mbH, Nexus Dx Inc., Omega Diagnostics Group Plc, OraSure Technologies Inc., QuidelOrtho Corp., Seramun Diagnostica GmbH, Siemens AG, SQI Diagnostics Inc., Sysmex Corp., Tecan Trading AG, Thermo Fisher Scientific Inc., and Werfenlife SA. Also, the immunodiagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Immunodiagnostics Market 2018 - 2022; Historic Market Size - Data Table on Global Immunodiagnostics Market 2018 - 2022 ($ million); 4.2 Product segment analysis 2018 - 2022; Historic Market Size - Product Segment 2018 - 2022 ($ million); 4.3 Application segment analysis 2018 - 2022; Historic Market Size - Application Segment 2018 - 2022 ($ million); 4.4 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product: 6.1 Market segments; Chart on Product - Market share 2023-2028 (%); Data Table on Product - Market share 2023-2028 (%); 6.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 6.3 Reagents and consumables - Market size and forecast 2023-2028; Chart on Reagents and consumables - Market size and forecast 2023-2028 ($ million); Data Table on Reagents and consumables - Market size and forecast 2023-2028 ($ million); Chart on Reagents and consumables - Year-over-year growth 2023-2028 (%); Data Table on Reagents and consumables - Year-over-year growth 2023-2028 (%); 6.4 Immunodiagnostic systems - Market size and forecast 2023-2028; Chart on Immunodiagnostic systems - Market size and forecast 2023-2028 ($ million); Data Table on Immunodiagnostic systems - Market size and forecast 2023-2028 ($ million); Chart on Immunodiagnostic systems - Year-over-year growth 2023-2028 (%); Data Table on Immunodiagnostic systems - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Product; Market opportunity by Product ($ million); Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Application: 7.1 Market segments; Chart on Application - Market share 2023-2028 (%); Data Table on Application - Market share 2023-2028 (%); 7.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 7.3 Oncology and endocrinology - Market size and forecast 2023-2028; Chart on Oncology and endocrinology - Market size and forecast 2023-2028 ($ million); Data Table on Oncology and endocrinology - Market size and forecast 2023-2028 ($ million); Chart on Oncology and endocrinology - Year-over-year growth 2023-2028 (%); Data Table on Oncology and endocrinology - Year-over-year growth 2023-2028 (%); 7.4 Hepatitis and retrovirus - Market size and forecast 2023-2028; Chart on Hepatitis and retrovirus - Market size and forecast 2023-2028 ($ million); Data Table on Hepatitis and retrovirus - Market size and forecast 2023-2028 ($ million); Chart on Hepatitis and retrovirus - Year-over-year growth 2023-2028 (%); Data Table on Hepatitis and retrovirus - Year-over-year growth 2023-2028 (%); 7.5 Infectious disease - Market size and forecast 2023-2028; Chart on Infectious disease - Market size and forecast 2023-2028 ($ million); Data Table on Infectious disease - Market size and forecast 2023-2028 ($ million); Chart on Infectious disease - Year-over-year growth 2023-2028 (%); Data Table on Infectious disease - Year-over-year growth 2023-2028 (%); 7.6 GI stool - Market size and forecast 2023-2028; Chart on GI stool - Market size and forecast 2023-2028 ($ million); Data Table on GI stool - Market size and forecast 2023-2028 ($ million); Chart on GI stool - Year-over-year growth 2023-2028 (%); Data Table on GI stool - Year-over-year growth 2023-2028 (%); 7.7 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ million); Data Table on Others - Market size and forecast 2023-2028 ($ million); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 7.8 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2023-2028 (%); Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 9.9 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.10 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ million); Data Table on Canada - Market size and forecast 2023-2028 ($ million); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.11 China - Market size and forecast 2023-2028; Chart on China - Market size and forecast 2023-2028 ($ million); Data Table on China - Market size and forecast 2023-2028 ($ million); Chart on China - Year-over-year growth 2023-2028 (%); Data Table on China - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 10.4 Market opportunities/restraints
11 Competitive Landscape: 11.1 Overview; 11.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 11.3 Landscape disruption; Overview on factors of disruption; 11.4 Industry risks; Impact of key risks on business
12 Competitive Analysis: 12.1 Companies profiled; Companies covered; 12.2 Market positioning of companies; Matrix on companies position and classification; 12.3 Abbott Laboratories; Abbott Laboratories - Overview; Abbott Laboratories - Business segments; Abbott Laboratories - Key news; Abbott Laboratories - Key offerings; Abbott Laboratories - Segment focus; 12.4 Adaptive Biotechnologies Corp.; Adaptive Biotechnologies Corp. - Overview; Adaptive Biotechnologies Corp. - Product / Service; Adaptive Biotechnologies Corp. - Key news; Adaptive Biotechnologies Corp. - Key offerings; 12.5 AESKU.GROUP GmbH and Co. KG; AESKU.GROUP GmbH and Co. KG - Overview; AESKU.GROUP GmbH and Co. KG - Product / Service; AESKU.GROUP GmbH and Co. KG - Key offerings; 12.6 bioMerieux SA; bioMerieux SA - Overview; bioMerieux SA - Product / Service; bioMerieux SA - Key news; bioMerieux SA - Key offerings; 12.7 Danaher Corp.; Danaher Corp. - Overview; Danaher Corp. - Business segments; Danaher Corp. - Key news; Danaher Corp. - Key offerings; Danaher Corp. - Segment focus; 12.8 DiaSorin SpA; DiaSorin SpA - Overview; DiaSorin SpA - Business segments; DiaSorin SpA - Key news; DiaSorin SpA - Key offerings; DiaSorin SpA - Segment focus; 12.9 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; 12.10 HUMAN Gesellschaft fur Biochemica und Diagnostica mbH; HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Overview; HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Product / Service; HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Key offerings; 12.11 OraSure Technologies Inc.; OraSure Technologies Inc. - Overview; OraSure Technologies Inc. - Business segments; OraSure Technologies Inc. - Key news; OraSure Technologies Inc. - Key offerings; OraSure Technologies Inc. - Segment focus; 12.12 QuidelOrtho Corp.; QuidelOrtho Corp. - Overview; QuidelOrtho Corp. - Product / Service; QuidelOrtho Corp. - Key offerings; 12.13 Siemens AG; Siemens AG - Overview; Siemens AG - Business segments; Siemens AG - Key news; Siemens AG - Key offerings; Siemens AG - Segment focus; 12.14 SQI Diagnostics Inc.; SQI Diagnostics Inc. - Overview; SQI Diagnostics Inc. - Product / Service; SQI Diagnostics Inc. - Key offerings; 12.15 Sysmex Corp.; Sysmex Corp. - Overview; Sysmex Corp. - Business segments; Sysmex Corp. - Key offerings; Sysmex Corp. - Segment focus; 12.16 Tecan Trading AG; Tecan Trading AG - Overview; Tecan Trading AG - Business segments; Tecan Trading AG - Key offerings; Tecan Trading AG - Segment focus; 12.17 Thermo Fisher Scientific Inc.; Thermo Fisher Scientific Inc. - Overview; Thermo Fisher Scientific Inc. - Business segments; Thermo Fisher Scientific Inc. - Key news; Thermo Fisher Scientific Inc. - Key offerings; Thermo Fisher Scientific Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 13.3 Currency conversion rates for US$; Currency conversion rates for US$; 13.4 Research methodology; Research methodology; 13.5 Data procurement; Information sources; 13.6 Data validation; Data validation; 13.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 13.8 Data synthesis; Data synthesis; 360 degree market analysis; 360 degree market analysis; 13.10 List of abbreviations; List of abbreviations

Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Market Segmentation by Application; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Parent Market; Exhibits11: Data Table on - Parent Market; Exhibits12: Market characteristics analysis; Exhibits13: Value Chain Analysis; Exhibits14: Offerings of companies included in the market definition; Exhibits15: Market segments; Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits20: Historic Market Size - Data Table on Global Immunodiagnostics Market 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Application Segment 2018 - 2022 ($ million); Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits25: Five forces analysis - Comparison between 2023 and 2028; Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits31: Chart on Market condition - Five forces 2023 and 2028; Exhibits32: Chart on Product - Market share 2023-2028 (%); Exhibits33: Data Table on Product - Market share 2023-2028 (%); Exhibits34: Chart on Comparison by Product; Exhibits35: Data Table on Comparison by Product; Exhibits36: Chart on Reagents and consumables - Market size and forecast 2023-2028 ($ million); Exhibits37: Data Table on Reagents and consumables - Market size and forecast 2023-2028 ($ million); Exhibits38: Chart on Reagents and consumables - Year-over-year growth 2023-2028 (%); Exhibits39: Data Table on Reagents and consumables - Year-over-year growth 2023-2028 (%); Exhibits40: Chart on Immunodiagnostic systems - Market size and forecast 2023-2028 ($ million); Exhibits41: Data Table on Immunodiagnostic systems - Market size and forecast 2023-2028 ($ million); Exhibits42: Chart on Immunodiagnostic systems - Year-over-year growth 2023-2028 (%); Exhibits43: Data Table on Immunodiagnostic systems - Year-over-year growth 2023-2028 (%); Exhibits44: Market opportunity by Product ($ million); Exhibits45: Data Table on Market opportunity by Product ($ million); Exhibits46: Chart on Application - Market share 2023-2028 (%); Exhibits47: Data Table on Application - Market share 2023-2028 (%); Exhibits48: Chart on Comparison by Application; Exhibits49: Data Table on Comparison by Application; Exhibits50: Chart on Oncology and endocrinology - Market size and forecast 2023-2028 ($ million); Exhibits51: Data Table on Oncology and endocrinology - Market size and forecast 2023-2028 ($ million); Exhibits52: Chart on Oncology and endocrinology - Year-over-year growth 2023-2028 (%); Exhibits53: Data Table on Oncology and endocrinology - Year-over-year growth 2023-2028 (%); Exhibits54: Chart on Hepatitis and retrovirus - Market size and forecast 2023-2028 ($ million); Exhibits55: Data Table on Hepatitis and retrovirus - Market size and forecast 2023-2028 ($ million); Exhibits56: Chart on Hepatitis and retrovirus - Year-over-year growth 2023-2028 (%); Exhibits57: Data Table on Hepatitis and retrovirus - Year-over-year growth 2023-2028 (%); Exhibits58: Chart on Infectious disease - Market size and forecast 2023-2028 ($ million); Exhibits59: Data Table on Infectious disease - Market size and forecast 2023-2028 ($ million); Exhibits60: Chart on Infectious disease - Year-over-year growth 2023-2028 (%); Exhibits61: Data Table on Infectious disease - Year-over-year growth 2023-2028 (%); Exhibits62: Chart on GI stool - Market size and forecast 2023-2028 ($ million); Exhibits63: Data Table on GI stool - Market size and forecast 2023-2028 ($ million); Exhibits64: Chart on GI stool - Year-over-year growth 2023-2028 (%); Exhibits65: Data Table on GI stool - Year-over-year growth 2023-2028 (%); Exhibits66: Chart on Others - Market size and forecast 2023-2028 ($ million); Exhibits67: Data Table on Others - Market size and forecast 2023-2028 ($ million); Exhibits68: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits69: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits70: Market opportunity by Application ($ million); Exhibits71: Data Table on Market opportunity by Application ($ million); Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits73: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits74: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits75: Chart on Geographic comparison; Exhibits76: Data Table on Geographic comparison; Exhibits77: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits85: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits86: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits87: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits88: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits93: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits94: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits95: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits96: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits101: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits102: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits103: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits104: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits105: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits106: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits107: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits108: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits109: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits110: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits111: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits112: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits113: Market opportunity By Geographical Landscape ($ million); Exhibits114: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits115: Impact of drivers and challenges in 2023 and 2028; Exhibits116: Overview on criticality of inputs and factors of differentiation; Exhibits117: Overview on factors of disruption; Exhibits118: Impact of key risks on business; Exhibits119: Companies covered; Exhibits120: Matrix on companies position and classification; Exhibits121: Abbott Laboratories - Overview; Exhibits122: Abbott Laboratories - Business segments; Exhibits123: Abbott Laboratories - Key news; Exhibits124: Abbott Laboratories - Key offerings; Exhibits125: Abbott Laboratories - Segment focus; Exhibits126: Adaptive Biotechnologies Corp. - Overview; Exhibits127: Adaptive Biotechnologies Corp. - Product / Service; Exhibits128: Adaptive Biotechnologies Corp. - Key news; Exhibits129: Adaptive Biotechnologies Corp. - Key offerings; Exhibits130: AESKU.GROUP GmbH and Co. KG - Overview; Exhibits131: AESKU.GROUP GmbH and Co. KG - Product / Service; Exhibits132: AESKU.GROUP GmbH and Co. KG - Key offerings; Exhibits133: bioMerieux SA - Overview; Exhibits134: bioMerieux SA - Product / Service; Exhibits135: bioMerieux SA - Key news; Exhibits136: bioMerieux SA - Key offerings; Exhibits137: Danaher Corp. - Overview; Exhibits138: Danaher Corp. - Business segments; Exhibits139: Danaher Corp. - Key news; Exhibits140: Danaher Corp. - Key offerings; Exhibits141: Danaher Corp. - Segment focus; Exhibits142: DiaSorin SpA - Overview; Exhibits143: DiaSorin SpA - Business segments; Exhibits144: DiaSorin SpA - Key news; Exhibits145: DiaSorin SpA - Key offerings; Exhibits146: DiaSorin SpA - Segment focus; Exhibits147: F. Hoffmann La Roche Ltd. - Overview; Exhibits148: F. Hoffmann La Roche Ltd. - Business segments; Exhibits149: F. Hoffmann La Roche Ltd. - Key news; Exhibits150: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits151: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits152: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Overview; Exhibits153: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Product / Service; Exhibits154: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Key offerings; Exhibits155: OraSure Technologies Inc. - Overview; Exhibits156: OraSure Technologies Inc. - Business segments; Exhibits157: OraSure Technologies Inc. - Key news; Exhibits158: OraSure Technologies Inc. - Key offerings; Exhibits159: OraSure Technologies Inc. - Segment focus; Exhibits160: QuidelOrtho Corp. - Overview; Exhibits161: QuidelOrtho Corp. - Product / Service; Exhibits162: QuidelOrtho Corp. - Key offerings; Exhibits163: Siemens AG - Overview; Exhibits164: Siemens AG - Business segments; Exhibits165: Siemens AG - Key news; Exhibits166: Siemens AG - Key offerings; Exhibits167: Siemens AG - Segment focus; Exhibits168: SQI Diagnostics Inc. - Overview; Exhibits169: SQI Diagnostics Inc. - Product / Service; Exhibits170: SQI Diagnostics Inc. - Key offerings; Exhibits171: Sysmex Corp. - Overview; Exhibits172: Sysmex Corp. - Business segments; Exhibits173: Sysmex Corp. - Key offerings; Exhibits174: Sysmex Corp. - Segment focus; Exhibits175: Tecan Trading AG - Overview; Exhibits176: Tecan Trading AG - Business segments; Exhibits177: Tecan Trading AG - Key offerings; Exhibits178: Tecan Trading AG - Segment focus; Exhibits179: Thermo Fisher Scientific Inc. - Overview; Exhibits180: Thermo Fisher Scientific Inc. - Business segments; Exhibits181: Thermo Fisher Scientific Inc. - Key news; Exhibits182: Thermo Fisher Scientific Inc. - Key offerings; Exhibits183: Thermo Fisher Scientific Inc. - Segment focus; Exhibits184: Inclusions checklist; Exhibits185: Exclusions checklist; Exhibits186: Currency conversion rates for US$; Exhibits187: Research methodology; Exhibits188: Information sources; Exhibits189: Data validation; Exhibits190: Validation techniques employed for market sizing; Exhibits191: Data synthesis; Exhibits192: 360 degree market analysis; Exhibits193: List of abbreviations